medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2024, Number 3

<< Back Next >>

Rev Mex Urol 2024; 84 (3)

Correlation of the severity of lower urinary tract symptoms with diabetes mellitus in the male population

Hernández-Vera BB, Morales-Pineda GX, Calderón-Lucas JF, Gómez-Franco TL, García-Martínez AF

Language: Spanish
References: 41
Page: 1-12
PDF size: 396.19 Kb.


ABSTRACT

Objective: Determine the correlation of the severity of LUTS with diabetes mellitus in the male population.
Material and methods: Cross-sectional and analytical study in a family medicine unit in Mexico City during the year 2022, in 275 subjects; The severity of the LUTS was evaluated using the Gea® Visual Analogue Scale, the measurement of Diabetes Mellitus (DM) was by its duration of evolution, in addition, the consumption of diuretics, coffee, beer and tobacco was studied. The analysis was by descriptive and inferential statistics using Spearman’s correlation coefficient (Rho).
Results: A significant correlation was only found in nocturia with DM (Rho 0.202) and average correlations with some of the LUTS in age, diuretics and smoking; 78.9 % reported a good quality of life.
Limitations of the study: Studying the phenomenon in a cross-sectional design as in previous research, and not in a longitudinal one.
Originality: measuring the amount of DM exposure and other covariates, allowing correlations to be made with the degrees of severity of LUTS, favoring the causality analysis of the dose-response gradient.
Conclusions: The correlations between diabetes and lower urinary tract symptoms were weak and medium, mostly non-significant, although there is literature mentioning this association, it is not enough to deduce that diabetes corresponds to a determining factor in the severity of LUTS.


REFERENCES

  1. Saigal Cs, Joyce G. Economic costs of benignprostatic hyperplasia in the private sector. TheJournal of Urology. 2005;173(4). https://doi.org/10.1097/01.ju.0000152318.79184.6f

  2. Abler LL, Vezina CM. Links between lowerurinary tract symptoms, intermittent hypoxiaand diabetes: Causes or cures? RespiratoryPhysiology & Neurobiology. 2018;256: 87–96.https://doi.org/10.1016/j.resp.2017.09.009

  3. Choi EPH, Wan EYF, Chin WY, Lam CLK.Lower urinary tract symptoms and healthrelatedquality of life in Hong Kong primarycare: a cross-sectional study. Quality of LifeResearch. 2020;29(5): 1311–1321. https://doi.org/10.1007/s11136-019-02402-7.

  4. Robertson C, Link CL, Onel E, Mazzetta C,Keech M, Hobbs R, et al. The impact of lowerurinary tract symptoms and comorbidities onquality of life: the BACH and UREPIK studies.BJU International. 2007;99(2): 347–354. https://doi.org/10.1111/j.1464-410X.2007.06609.x.

  5. Boyle P, Robertson C, Mazzetta C, Keech M,Hobbs R, Fourcade R, et al. The relationshipbetween lower urinary tract symptomsand health status: the UREPIK study. BJUInternational. 2003;92(6): 575–580. https://doi.org/10.1046/j.1464-410X.2003.04448.x.

  6. Przydacz M, Skalski M, Sobanski J, ChlostaM, Raczynski K, Klasa K, et al. Associationbetween Lower Urinary Tract Symptoms andSleep Quality of Patients with Depression.Medicina. 2021;57(4): 394. https://doi.org/10.3390/medicina57040394.

  7. Perchon LFG, Pintarelli VL, Bezerra E, ThielM, Dambros M. Quality of life in elderlymen with aging symptoms and lower urinarytract symptoms (LUTS). Neurourology andUrodynamics. 2011;30(4): 515–519. https://doi.org/10.1002/nau.21008.

  8. Zheng Y, Ley SH, Hu FB. Global aetiology andepidemiology of type 2 diabetes mellitus and itscomplications. Nature Reviews Endocrinology.2018;14(2): 88–98. https://doi.org/10.1038/nrendo.2017.151.

  9. Boon TA, van Venrooij GEPM, Eckhardt MD.Effect of diabetes mellitus on lower urinarytract symptoms and dysfunction in patientswith benign prostatic hyperplasia. CurrentUrology Reports. 2001;2(4): 297–301. https://doi.org/10.1007/s11934-001-0067-z.

  10. Madersbacher S, Sampson N, Culig Z.Pathophysiology of Benign ProstaticHyperplasia and Benign Prostatic Enlargement:A Mini-Review. Gerontology. 2019;65(5): 458–464. https://doi.org/10.1159/000496289.

  11. Sebastianelli A, Gacci M. Current Status ofthe Relationship Between Metabolic Syndromeand Lower Urinary Tract Symptoms. EuropeanUrology Focus. 2018;4(1): 25–27. https://doi.org/10.1016/j.euf.2018.03.007.

  12. Tam CA, Helfand BT, Erickson BA. TheRelationship Between Diabetes, DiabetesSeverity, Diabetes Biomarkers, and thePresence of Lower Urinary Tract Symptoms:Findings From the National Health andNutrition Examination Survey. Urology.2017;105: 141–148. https://doi.org/10.1016/j.urology.2017.03.040.

  13. Vinik AI, Maser RE, Mitchell BD, FreemanR. Diabetic Autonomic Neuropathy. DiabetesCare. 2003;26(5): 1553–1579. https://doi.org/10.2337/diacare.26.5.1553.

  14. Sarma AV, Sauver JLS, Hollingsworth JM,Jacobson DJ, McGree ME, Dunn RL, et al.Diabetes Treatment and Progression of BenignProstatic Hyperplasia in Community-dwellingBlack and White Men. Urology. 2012;79(1):102–108. https://doi.org/10.1016/j.urology.2011.08.065.

  15. Menendez V, Cofan F, Talbot-Wright R, RicartMJ, Gutierrez R, Carretero P. UrodynamicEvaluation in Simultaneous Insulin-DependentDiabetes Mellitus and End Stage Renal Disease.The Journal of Urology. 1996;155(6). https://doi.org/10.1016/S0022-5347(01)66074-9.

  16. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS,Schoenberg ED, Owen-Smith A, et al. PatientMisunderstanding of the Individual Questions ofthe American Urological Association SymptomScore. The Journal of Urology. 2008;179(6).https://doi.org/10.1016/j.juro.2008.01.140.

  17. Barry MJ, Fowler FJ, O’Leary MP, BruskewitzRC, Holtgrewe HL, Mebust WK, et al. TheAmerican Urological Association SymptomIndex for Benign Prostatic Hyperplasia. TheJournal of Urology. 1992;148(1). https://doi.org/10.1016/s0022-5347(17)36966-5.

  18. Johnson TV, Schoenberg ED, Abbasi A, EhrlichSS, Kleris R, Owen-Smith A, et al. Assessmentof the Performance of the American UrologicalAssociation Symptom Score in 2 Distinct PatientPopulations. The Journal of Urology. 2009;181(1).https://doi.org/10.1016/j.juro.2008.09.010.

  19. Preciado-Estrella DA, Kaplan SA, Iturriaga-Goyón E, Ramón-Trejo E, Mayorga-Gómez E,Auza-Benavides A, et al. Comparación del ÍndiceInternacional de Síntomas Prostáticos versusEscala Visual Análoga Gea® para la evaluaciónde los síntomas de la vía urinaria inferior.Revista mexicana de urología. 2017;77(5): 372–382. https://doi.org/10.24245/revmexurol.v77i5.1125.

  20. Daneshgari F, Liu G, Hanna-Mitchell AT.Path of translational discovery of urologicalcomplications of obesity and diabetes.American Journal of Physiology-Renal Physiology.2017;312(5): F887–F896. https://doi.org/10.1152/ajprenal.00489.2016.

  21. Costa HMLM, Popovicz D, Paes RG, AssisGM, Esmanhotto TC, Erzinger AR. Associaçãoentre neuropatia diabética e sintomas de tratourinário inferior nas pessoas com diabetesmellitus: revisão integrativa. Revista EletrônicaAcervo Saúde. 2020;12(12): e5574. https://doi.org/10.25248/reas.e5574.2020.

  22. Qasrawi H, Tabouni M, Almansour SW,Ghannam M, Abdalhaq A, Abushamma F, et al.An evaluation of lower urinary tract symptomsin diabetic patients: a cross-sectional study.BMC Urology. 2022;22(1): 178. https://doi.org/10.1186/s12894-022-01133-1.

  23. Erdogan BR, Liu G, Arioglu-Inan E, MichelMC. Established and emerging treatmentsfor diabetes-associated lower urinary tractdysfunction. Naunyn-Schmiedeberg’s Archives ofPharmacology. 2022;395(8): 887–906. https://doi.org/10.1007/s00210-022-02249-9.

  24. Tai HC, Tai TY, Yang WS, Wang SW, Yu HJ.Associations between lower urinary tractdysfunction and glycemic control in women withtype 2 diabetes: A cross-sectional study. Journalof Diabetes and its Complications. 2016;30(3):415–419. https://doi.org/10.1016/j.jdiacomp.2016.01.002.

  25. Lombardo R, Tubaro A, Burkhard F. Nocturia:The Complex Role of the Heart, Kidneys, andBladder. European Urology Focus. 2020;6(3):534–536. https://doi.org/10.1016/j.euf.2019.07.007.

  26. Ohishi M, Kubozono T, Higuchi K, AkasakiY. Hypertension, cardiovascular disease,and nocturia: a systematic review of thepathophysiological mechanisms. HypertensionResearch. 2021;44(7): 733–739. https://doi.org/10.1038/s41440-021-00634-0.

  27. Feldstein CA. Nocturia in arterial hypertension:a prevalent, underreported, and sometimesunderestimated association. Journal of theAmerican Society of Hypertension. 2013;7(1): 75–84. https://doi.org/10.1016/j.jash.2012.12.004.

  28. Johnson II TM, Sattin RW, Parmelee P, FultzNH, Ouslander JG. Evaluating PotentiallyModifiable Risk Factors for Prevalent andIncident Nocturia in Older Adults. Journal ofthe American Geriatrics Society. 2005;53(6):1011–1016. https://doi.org/10.1111/j.1532-5415.2005.53321.x.

  29. Chen FY, Dai YT, Liu CK, Yu HJ, Liu CY,Chen THH. Perception of nocturia and medicalconsulting behavior among communitydwellingwomen. International UrogynecologyJournal. 2007;18(4): 431–436. https://doi.org/10.1007/s00192-006-0167-x.

  30. Yoshimura K. Correlates for nocturia: A reviewof epidemiological studies. International Journalof Urology. 2012;19(4): 317–329. https://doi.org/10.1111/j.1442-2042.2011.02956.x.

  31. Welliver C, Sulaver R, Whittington A, HelfandBT, Çakır ÖO, Griffith JW, et al. AnalyzingWhy Men Seek Treatment for Lower UrinaryTract Symptoms and Factors AssociatedWith Nonimprovement. Urology. 2015;86(5):862–867. https://doi.org/10.1016/j.urology.2015.08.006.

  32. Conchado J, Álvarez R, Serrano C. Benignprostatic hyperplasia and lower tract urinarytract symptoms. Revi Cubana Med Gen Itegr2021; 37(1): 1-14.

  33. Maserejian NN, Chen S, Chiu GR, Araujo AB,Kupelian V, Hall SA, et al. Treatment Statusand Progression or Regression of Lower UrinaryTract Symptoms in a General Adult PopulationSample. The Journal of Urology. 2014;191.https://doi.org/10.1016/j.juro.2013.07.005.

  34. Alcántara Montero A, Brenes Bermúdez FJ,Pérez Feito D. Relationship between lowerurinary tract symptoms in men and erectiledysfunction. Semergen. 2016;42(3): 164–171.https://doi.org/10.1016/j.semerg.2015.07.005.

  35. Jura YH, Townsend MK, Curhan GC, ResnickNM, Grodstein F. Caffeine Intake, and theRisk of Stress, Urgency and Mixed UrinaryIncontinence. The Journal of Urology. 2011;185.https://doi.org/10.1016/j.juro.2011.01.003

  36. Bird ET, Parker BD, Kim HS, Coffield KS.Caffeine ingestion and lower urinary tractsymptoms in healthy volunteers. Neurourologyand Urodynamics. 2005;24(7): 611–615. https://doi.org/10.1002/nau.20179.

  37. Staack A, Distelberg B, Schlaifer A, Sabaté J.Prospective study on the effects of regular anddecaffeinated coffee on urinary symptoms inyoung and healthy volunteers. Neurourology andUrodynamics. 2017;36(2): 432–437. https://doi.org/10.1002/nau.22949.

  38. Kennedy OJ, Pirastu N, Poole R, FallowfieldJA, Hayes PC, Grzeszkowiak EJ, et al.Coffee Consumption and Kidney Function: AMendelian Randomization Study. AmericanJournal of Kidney Diseases. 2020;75(5): 753–761.https://doi.org/10.1053/j.ajkd.2019.08.025.

  39. Kovalev AV, Nikitin AM, Romanenko GH,Zavalishina LE. Pathomorphological alterationsin the kidneys in acute and chronic alcoholintoxication. Sudebno-Meditsinskaia Ekspertiza.2022;65(1): 52–56. https://doi.org/10.17116/sudmed20226501152.

  40. Jain G, Jaimes EA. Nicotine signaling andprogression of chronic kidney disease insmokers. Biochemical Pharmacology. 2013;86(8):1215–1223. https://doi.org/10.1016/j.bcp.2013.07.014.

  41. Ates M, Hosgorler F, Yuksel O, Unsal SK,Guvendi G, Karakilic A, et al. Nicotineincreased VEGF and MMP2 levels in the rat eyeand kidney. Environmental Science and PollutionResearch. 2019;26(32): 33517–33523. https://doi.org/10.1007/s11356-019-06460-9.




2020     |     www.medigraphic.com